By David Shepardson WASHINGTON (Reuters) – TikTok’s fortunes took a positive turn on Thursday as a growing number of U.S. officials said its
By David Shepardson WASHINGTON (Reuters) – A growing number of lawmakers are urging President Joe Biden to grant a reprieve to prevent TikTok
WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Thursday it has referred to the Justice Department a complaint against Snap
By Ron Bousso LONDON (Reuters) -BP will cut over 5% of its global workforce, it said on Thursday, as part of CEO Murray
(Reuters) – Colonial Pipeline has made progress in identifying the source of a leak on its main gasoline artery and estimates Line
The announcement by Meta CEO Mark Zuckerberg that Facebook and Instagram would end their work with third-party fact-checkers and ease certain content
The FBI has closed its DEI office, Fox News can confirm. ‘In recent weeks, the FBI took steps to close the Office
Democrat Sen. Mazie Hirono of Hawaii faced mockery on social media on Thursday over her opening questions to Interior Secretary nominee Doug
Former North Dakota Gov. Doug Burgum, President-elect Trump’s nominee for interior secretary, was pressed by the Senate on his environmental agenda and
NEWYou can now listen to Fox News articles! This past July, as anti-Israel crowds took to the streets of Washington, D.C,,
Pam Bondi, President-elect Trump’s nominee to lead the Department of Justice, was involved in a sharp clash with Sen. Adam Schiff, D-Calif.,
SAO PAULO (Reuters) – The final version of the Brazilian tax reform sanctioned on Thursday by Brazil President Luiz Inacio Lula da
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets. Relief from the positive U.S. and UK inflation surprises this
(Reuters) – FBI leaders have warned that hackers who breached AT&T (NYSE:T)’s system last year likely stole months of agents’ call and
(Reuters) – A federal judge on Thursday dismissed a lawsuit accusing Lyft (NASDAQ:LYFT) of defrauding shareholders by waiting too long
By Blake Brittain WASHINGTON – Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis (SIX:NOVN)’
